Page 24 - G. Cell differentiation. division. and death
P. 24

[G. Cell differentiation, division, and death-17]



              Identification of natural compound inhibitors of ferroptosis


                                              in cardiomyocytes




                          Jeong Eun Lee¹˙², Kwang-Hee Bae¹˙², Sang Chul Lee¹˙², Eun-Woo Lee¹

        ¹Metabolic Regulation Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon

         34141, Korea, ²Department of Functional Genomics, University of Science and Technology (UST), Daejeon 34141,
                                                          Korea




        Cardiomyocyte death during myocardial infarction (MI) plays a key role in cardiac damage and heart failure. Recently,

        it has been reported that ferroptosis, an iron-dependent non-apoptotic cell death, contributes to myocardial cell

        death during MI. Therefore, ferroptosis inhibitors are expected as potential drugs for heart failure. In this study, we
        investigated natural compounds for their potential as ferroptosis inhibitors using natural products library which
        contains about 658 single compounds. To test this, ferroptosis was induced by the treatment with glutathione

        peroxidase 4 (GPX4) inhibitor RSL3 in the presence of natural compounds in H9c2 cardiomyoblasts and cell viability
        were measured. As a result, we found several natural compounds, which significantly inhibited ferroptosis induced

        by GPX4 inhibition or cysteine deprivation. Since lipid peroxidation is a hallmark of ferroptosis, the levels of lipid
        peroxide were  determined by  flow cytometry using  the fluorescent  probe  C11-BODIPY.  Furthermore,  several

        compounds  did  not  inhibit  H2O2-induced  cell  death,  implying  that  these  compounds  might  not  be  general
        antioxidant.  In  summary,  our  data  identify  several  natural  compounds  as  novel  ferroptosis  inhibitors  in

        cardiomyocytes and potential therapeutic agents against MI.
   19   20   21   22   23   24   25   26   27   28   29